Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

NCT05264051 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT05264051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Recruiting
Start date
April 18, 2022
Completion date
March 1, 2027
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver diseases